This inventor holds 1 USPTO granted patent. Top assignee: Abbott Products Gmbh. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: The Innovations of Johannes Bernardus Everardus Hulshof
Introduction
Johannes Bernardus Everardus Hulshof is a notable inventor based in VH Eelde, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific enzymes related to steroid hormone-dependent diseases.
Latest Patents
Hulshof holds a patent for "17β-hydroxysteroid dehydrogenase type I inhibitors - 3,15-substituted estrone compounds." This invention focuses on inhibitors of 17β-hydroxysteroid dehydrogenase type I (17β-HSD1), including salts, pharmaceutical preparations, and processes for preparing these compounds. The therapeutic uses of these compounds are particularly relevant in treating or inhibiting steroid hormone-dependent diseases or disorders, such as endometriosis.
Career Highlights
Hulshof is currently associated with Abbott Products GmbH, where he continues to innovate in the pharmaceutical sector. His work has implications for the treatment of various gynecological disorders, showcasing his commitment to advancing medical science.
Collaborations
Hulshof has collaborated with notable colleagues, including Nina Johansson and Bettina Husen, contributing to a dynamic research environment that fosters innovation.
Conclusion
Johannes Bernardus Everardus Hulshof's work exemplifies the intersection of innovation and healthcare, with his patent addressing critical medical needs. His contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile